Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-10
2000-05-02
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514510, 514824, A61K 31445, A61K 3121
Patent
active
060573392
ABSTRACT:
A method is provided for inhibiting onset of or treating phytosterolemia by administering to a patient an MTP inhibitor, alone or optionally, in combination with another cholesterol lowering drug, such as pravastatin.
REFERENCES:
patent: 5502045 (1996-03-01), Miettinen et al.
patent: 5712279 (1998-01-01), Biller et al.
Scriver et al, "The Metabolic and Molecular Bases of Inherited Disease", Seventh Edition, vol. II, Bjorkhem et al, "Inborn Errors in Bile Acid Biosynthesis and Storage of Sterols Othern Than Cholesterol", pp. 2073-2099, (1995).
Cobb et al, "Sitosterolemia-Opposing Effects of Cholestytamine and Lovastatin on Plasma Sterol Levels in a Homozygous Girl and Her Heterozygous Father", (Rockefeller Univ., Biochem. Genet & Betab Lab, New York, NY), Abstract No. 96:434984, Metabolism-Clinical and Experimental, vol. 45, No. 6, pp. 673-679, Jun. 1996.
CA: 124:174453, Parsons et al., 1995.
CA 125:132403, Hidaka et al., 1995.
Bristol--Myers Squibb Company
Hermenau Ronald S.
Jordan Kimberly
Rodney Burton
LandOfFree
Method of inhibiting or treating phytosterolemia with an MTP inh does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting or treating phytosterolemia with an MTP inh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting or treating phytosterolemia with an MTP inh will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1594144